advocacy highlights

• Capital Access.  Capital is a critical need of all bioscience companies.  NCBIO works constantly to expand public investments in bioscience companies and life-science venture funds, loans for bioscience businesses, and tax incentives for investments and research.
• Workforce Training and Education.  Bioscience companies require highly educated scientists, laboratory technicians, manufacturing workers and other trained employees.  North Carolina is spending more than $60 million on the new NCBIOIMPACT training consortium proposed by NCBIO.  NCBIO is coordinating industry support and input for the Consortium.
• University Research and Technology Transfer.  Basic research is a wellspring of bioscience technology and business growth.  NCBIO works to expand state funding for life science research grants and to protect and enhance university access to federal research dollars.
• Tax and Regulatory Issues.  Bioscience companies grow best in a nurturing business climate.  NCBIO supports favorable tax treatment for biomanufacturing research and manufacturing expansions, government support for bioscience-related infrastructure. The Organization also aggressively opposes initiatives that depress the price of drugs and other health care products and seeks to assure that any new regulation of bioscience technologies is both necessary and rationale